Navigation Links
Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
Date:7/29/2008

GeneXpert Infinity-48 is the World's First Fully-Automated Random Access

Molecular Diagnostic Testing System; On Display at AACC Meeting

SUNNYVALE, Calif., July 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today introduced its GeneXpert(R) Infinity-48 high-throughput system at the 2008 American Association for Clinical Chemistry Annual Meeting in Washington, D.C. The newest addition to Cepheid's GeneXpert family of molecular diagnostic testing systems delivers the world's first and only fully-automated random access system designed for management of the entire molecular testing workflow. After a sample is loaded into a GeneXpert cartridge, the Infinity-48 System does the rest -- sample in, answer out. The Infinity-48 manages the sample data, cartridge loading and unloading and reporting of test results.

"Cepheid's GeneXpert Infinity-48 System represents the pinnacle of molecular diagnostics automation today," said Cepheid CEO John Bishop. "With an expanding pipeline of on-demand tests in the Infectious Disease, Oncology, and Genetic Disease markets, the Infinity Series of Systems is positioned to become the platform of choice for high-throughput laboratories."

Cepheid's GeneXpert Infinity-48 System uses robotic cartridge handling, managed by Cepheid's Xpertise(TM) software package and full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period, depending upon test selection. With each of the system's 48 testing modules managed as an independent testing site, the Infinity-48 System can start test runs anytime samples are collected -- 24 hours a day, 365 days a year. Delivering true walk away ease-of-use, the Infinity-48 System is positioned to improve workflow while further accelerating time-to-result, enabling healthcare providers to make more informed patient management and treatment decisions.

The Infinity-48 System can be configured with 16, 24, 32, 40, or 48 modules. To han
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cepheid Reports Second Quarter Revenue of $42.1 Million
2. Cepheid to Webcast Analyst Event
3. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
4. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
5. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
6. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
7. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
8. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
9. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
(Date:11/5/2009)...TRANSPORTATION -- Gone hybrid . . . , Fuel eco...es are now posted at the www.fueleconomy.gov web...ed and maintains for the U.S. Department of Energy...e of the top 10 vehicles on the best fuel economy ... (51 MPG city; 48 highway). "This list proves that...
(Date:11/5/2009)... PARSIPPANY, N.J., Nov. 5 DSM Phar...de a manufacturing alliance with Galenix, Saint Je...d commercial scale manufacturing partner for Galen...M and Galenix will collaborate on business develop...ery technologies, based on the strength of Galenix...
(Date:11/5/2009)... Conference Call on Thursday, November 5, 2009 at ...OUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Ph... (NASDAQ: OGXI ) today reported unaudited financi...nded September 30, 2009 and reviewed the Company,s...he following consolidated results reflect the oper...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...chnologies,Corporation, a leader in tumor-targeted...l European patents for the platform targeting tech...on gene delivery to primary cancers and,metastatic...h profound,demonstrations of clinical benefit and ...Epeius Biotech continues to lead the field of clin...
...siva,Inc. (Nasdaq: ANSV ) today announced top-li...ng Adlea(TM), its long-acting, non-opioid analgesi...dpoint of reducing post-surgical,pain versus place..., or total,knee replacement surgery) at four to 48...econdary endpoint with Adlea demonstrating a highl...
...alize Colorectal Cancer Treatment Determining Who ...KS, Calif., Dec. 16 Amgen (Nasdaq: AMGN ) today ...f the KRAS gene as a predictive biomarker in pat...ated with anti-epidermal growth factor receptor (E....S. Food and Drug Administration,s (FDA) Oncologic...
Other Biology Technology:Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 2Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 3Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 4Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 2Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 3Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 4Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 5Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 6Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 7Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 8
(Date:11/4/2009)...rstCall/ -- BIO-key International, Inc. (OTC Bulle...ic identification software is showcasing donor and...rence being held at the New Orleans Convention Cen...hands-on product demonstrations of its state-of-th...o, at 5 PM on Monday, October 26, Peter Lux, manag...
(Date:11/4/2009)...encoe Software, Inc., the commercial arm of the Op...://openmicroscopy.org ), is proud to announce its...iology,s exciting new project titled "The Cell: An... stimulus grant through the National Institutes of...rt of the American Reinvestment and Recovery Act, ...
(Date:11/3/2009)...published in a recent issue of HortTechnology , s...the effects of covering orchard floors with reflec...ight distribution, orchard temperature, and profit...nday and Solarmate films installed 5 weeks before ...pples. The research showed that the use of both fi...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 1China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 2China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 3China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 4Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2
...anes, submarines and even automobiles of tomorrow ...rformance micro-mechanical gyroscopes for navigati...EMS gyroscope arrays being developed by a team con...avrik of Oak Ridge National Laboratory is radicall... and costly. Instead, this system consists of mult...
...this summer where the tiger,s roar will meet birds...ll be heard next door to advanced sonar systems; w... the smashing falls of Antarctic ice shelves. , ...d to them -- will only be found at the Acoustics,0... Friday July 4, 2008 at the Palais des Congrs in P...
...r Medical Research, led by Jos Luis Milln, Ph.D., ... of enzyme replacement therapy to prevent hypophos...tic origin. This discovery lays the foundation fo...ckets is a softening of the bones that most common... from insufficient exposure to sunlight. Hypophosp...
Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, June 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, June 2008 3Potential therapy discovered for hypophosphatasia, a congenital form of rickets 2
Rabbit Anti-Bcl-G, C-Terminus Polyclonal Antibody, Unconjugated from AnaSpec
Rabbit Anti-Mouse sRANKL Antibody, Biotin Conjugated from Cell Sciences
Rabbit Anti-L-isoleucine Antibody, Unconjugated from QED Bioscience Inc.
Anti-TIMP-4 (Tissue Inhibitor of Metalloproteinases-4), Loop #3 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: